257 related articles for article (PubMed ID: 28322465)
21. Extending the treatment options in alcohol dependence: a randomized controlled study of as-needed nalmefene.
Mann K; Bladström A; Torup L; Gual A; van den Brink W
Biol Psychiatry; 2013 Apr; 73(8):706-13. PubMed ID: 23237314
[TBL] [Abstract][Full Text] [Related]
22. In vivo characterization of the opioid antagonist nalmefene in mice.
Osborn MD; Lowery JJ; Skorput AG; Giuvelis D; Bilsky EJ
Life Sci; 2010 Apr; 86(15-16):624-30. PubMed ID: 20159022
[TBL] [Abstract][Full Text] [Related]
23. Pharmacological evidence for a motivational role of kappa-opioid systems in ethanol dependence.
Walker BM; Koob GF
Neuropsychopharmacology; 2008 Feb; 33(3):643-52. PubMed ID: 17473837
[TBL] [Abstract][Full Text] [Related]
24. Nalmefene causes greater hypothalamic-pituitary-adrenal axis activation than naloxone in normal volunteers: implications for the treatment of alcoholism.
Schluger JH; Ho A; Borg L; Porter M; Maniar S; Gunduz M; Perret G; King A; Kreek MJ
Alcohol Clin Exp Res; 1998 Oct; 22(7):1430-6. PubMed ID: 9802524
[TBL] [Abstract][Full Text] [Related]
25. Who Receives Nalmefene and How Does It Work in the Real World? A Single-Arm, Phase IV Study of Nalmefene in Alcohol Dependent Outpatients: Baseline and 1-Month Results.
Barrio P; Ortega L; Guardia J; Roncero C; Yuguero L; Gual A
Clin Drug Investig; 2018 Feb; 38(2):147-155. PubMed ID: 29080208
[TBL] [Abstract][Full Text] [Related]
26. Nalmefene: a long-acting opioid antagonist. Clinical applications in emergency medicine.
Wang DS; Sternbach G; Varon J
J Emerg Med; 1998; 16(3):471-5. PubMed ID: 9610980
[TBL] [Abstract][Full Text] [Related]
27. Withdrawal syndrome after co-medication of opioid maintenance therapy with nalmefene: unrecognized interaction.
Diot C; Eiden C; Roussin A; Batisse A; Boucher A; Chavant F; Daveluy A; Donadieu-Rigole H; Peyrière H;
Eur J Clin Pharmacol; 2015 Dec; 71(12):1539-40. PubMed ID: 26329380
[No Abstract] [Full Text] [Related]
28. Opioid antagonists in the treatment of alcohol dependence.
O'Leary G; Borrow J; Weiss RD
Curr Psychiatry Rep; 2001 Dec; 3(6):484-8. PubMed ID: 11707162
[TBL] [Abstract][Full Text] [Related]
29. Nalmefene induced elevation in serum prolactin in normal human volunteers: partial kappa opioid agonist activity?
Bart G; Schluger JH; Borg L; Ho A; Bidlack JM; Kreek MJ
Neuropsychopharmacology; 2005 Dec; 30(12):2254-62. PubMed ID: 15988468
[TBL] [Abstract][Full Text] [Related]
30. Targeted nalmefene with simple medical management in the treatment of heavy drinkers: a randomized double-blind placebo-controlled multicenter study.
Karhuvaara S; Simojoki K; Virta A; Rosberg M; Löyttyniemi E; Nurminen T; Kallio A; Mäkelä R
Alcohol Clin Exp Res; 2007 Jul; 31(7):1179-87. PubMed ID: 17451401
[TBL] [Abstract][Full Text] [Related]
31. The effects of nalmefene on emotion processing in alcohol use disorder - A randomized, controlled fMRI study.
Vollstädt-Klein S; Bumb JM; Otto A; Dinter C; Karl D; Koopmann A; Hermann D; Mann K; Kiefer F
Eur Neuropsychopharmacol; 2019 Dec; 29(12):1442-1452. PubMed ID: 31740271
[TBL] [Abstract][Full Text] [Related]
32. Safety and tolerability of as-needed nalmefene in the treatment of alcohol dependence: results from the Phase III clinical programme.
van den Brink W; Strang J; Gual A; Sørensen P; Jensen TJ; Mann K
Expert Opin Drug Saf; 2015 Apr; 14(4):495-504. PubMed ID: 25652768
[TBL] [Abstract][Full Text] [Related]
33. A Case of Delirium and Rhabdomyolysis in Severe Iatrogenic Opioid Withdrawal.
Hanna J; Swetter S
Psychosomatics; 2018; 59(4):405-407. PubMed ID: 29325983
[No Abstract] [Full Text] [Related]
34. Problem drinking and low-dose naltrexone-assisted opioid detoxification.
Mannelli P; Peindl K; Patkar AA; Wu LT; Tharwani HM; Gorelick DA
J Stud Alcohol Drugs; 2011 May; 72(3):507-13. PubMed ID: 21513688
[TBL] [Abstract][Full Text] [Related]
35. Opioid-dependent error processing.
Fellows-Smith J
J Opioid Manag; 2011; 7(6):443-9. PubMed ID: 22320026
[TBL] [Abstract][Full Text] [Related]
36. [Pharmacological profile and clinical findings of nalmefene (Selincro
Tadori Y
Nihon Yakurigaku Zasshi; 2020; 155(2):113-119. PubMed ID: 32115477
[TBL] [Abstract][Full Text] [Related]
37. ▼Nalmefene for alcohol dependence.
Drug Ther Bull; 2014 May; 52(5):54-7. PubMed ID: 24809337
[TBL] [Abstract][Full Text] [Related]
38. New directions in the treatment of opioid withdrawal.
Srivastava AB; Mariani JJ; Levin FR
Lancet; 2020 Jun; 395(10241):1938-1948. PubMed ID: 32563380
[TBL] [Abstract][Full Text] [Related]
39. Naltrexone implant treatment for buprenorphine dependence--Mauritian case series.
Jhugroo A; Ellayah D; Norman A; Hulse G
J Psychopharmacol; 2014 Aug; 28(8):800-3. PubMed ID: 24695742
[TBL] [Abstract][Full Text] [Related]
40. [Nalmefene: a novel pharmacotherapeutic option for alcoholism].
Soyka M
Nervenarzt; 2014 May; 85(5):578-82. PubMed ID: 24126432
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
